Nephros (NEPH) Return on Capital Employed (2011 - 2026)

Nephros' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 6.05% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 169.0% year-over-year to 6.05%; the TTM figure through Mar 2026 stood at 6.05% (down 169.0% YoY), while the FY2025 annual figure was 11.87%, up 1181.0% from the prior year.
• Return on Capital Employed was 6.05% for Q1 2026 at Nephros, down from 10.73% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 14.06% in Q3 2025 to a low of 44.44% in Q4 2022.
• Historically, Return on Capital Employed has averaged 13.23% across 5 years, with a median of 15.31% in 2024.
• The sharpest annual moves came in 2022 and 2025: Return on Capital Employed slumped 2060 bps in 2022, then surged 2777 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 44.44% in 2022, then jumped by 61 bps to 17.17% in 2023, then surged by 100 bps to 0.06% in 2024, then surged by 16422 bps to 10.73% in 2025, then plunged by 44 bps to 6.05% in 2026.
• The last three Return on Capital Employed figures came in at 6.05% (Q1 2026), 10.73% (Q4 2025), and 14.06% (Q3 2025), per Business Quant data.